Thus, PGRN has the potential to influence susceptibility to a wide range of neurodegenerative diseases, including motor neuron disease, lysosomal storage disease, Huntington’s disease, and Alzheimer’s disease [3], [17]–[19]. This evidence concerns the gene GRN and juvenile Huntington disease.